The prolyl oligopeptidase family

Cellular and Molecular Life Sciences

Volumn 59, Issue 2, 2002, Pages 349-362

  Polgar L ^a  

^a INSTITUTE OF ENZYMOLOGY   (Hungary)

Author keywords

propeller structure; Acylaminoacyl peptidase; Catalytic mechanism; Dipeptidyl peptidase; Oligopeptidase B; Oligopeptidases; Prolyl oligopeptidase; Serine peptidases

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; PROLYL ENDOPEPTIDASE; SUBTILISIN; TRYPSIN;

AMNESIA; BLOOD PRESSURE REGULATION; CATALYSIS; CRYSTAL STRUCTURE; DEPRESSION; DRUG TARGETING; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN STRUCTURE; REVIEW; TRYPANOSOMIASIS;

ANIMALS; ANTIGENS, CD26; BINDING SITES; CATALYSIS; HUMANS; KINETICS; MODELS, MOLECULAR; OLIGOPEPTIDES; PEPTIDE HYDROLASES; PROTEIN STRUCTURE, TERTIARY; SERINE ENDOPEPTIDASES;

EID: 0036178438     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8427-5     Document Type: Review

References (156)

1. A new family of serine-type peptidases related to prolyl oligopeptidase
2. Protease II from Escherichia coli: Sequencing and expression of the enzyme gene and characterization of the expressed enzyme
3. Families of serine peptidases
4. Structural relationship between lipases and peptidases of the prolyl oligopeptidase family
5. The purification, characterization and analysis of primary and secondary-structure of prolyl oligopeptidase from human lymphocytes. Evidence that the enzyme belongs to the α/β hydrolase fold family
6. Prolyl oligopeptidase: An unusual β-propeller domain regulates proteolysis
7. Catalysis of serine oligopeptidases is controlled by a gating filter mechanism
8. Leucylglycinamide released from oxytocin by human uterine enzyme
9. Post-proline cleaving enzyme. Purification of this endopeptidase by affinity chromatography
10. Susceptibility of a peptide derived from bradykinin to hydrolysis by endooligopeptidases and pancreatic proteinases
11. Prolyl endopeptidase
12. Proline residues in the maturation and degradation of peptide-hormones and neuropeptides
13. Proline specific peptidases
14. Prolyl oligopeptidases
15. Substrate- and pH-dependent contribution of oxyanion binding site to the catalysis of prolyl oligopeptidase, a paradigm of the serine oligopeptidase family
16. cDNA cloning of porcine brain prolyl endopeptidase and identification of the active-site seryl residue
17. Prolyl endopeptidase from Flavobacterium meningosepticum: Cloning and sequencing of the enzyme gene
18. Characterization of prolyl oligopeptidase from Flavobacterium meningosepticum
19. Cloning of proline-specific endopeptidase gene from Ftavobacterium meningosepticum: Expression in Eseheriehia coli and purification of the heterologous protein
20. Cloning and sequence analysis of the gene encoding human lymphocyte prolyl endopeptidase
21. Molecular cloning and characterization of prolyl endopeptidase from human T cells
22. cDNA cloning of mouse prolyl endopeptidase and its involvement in DNA synthesis by Swiss 3T3 cells
23. Cloning and expression of the cDNA encoding prolyl oligopeptidase (prolyl endopeptidase) from bovine brain
24. Molecular cloning of cDNA for Sarcophaga prolyl endopeptidase and characterization of the recombinant enzyme produced by an E. coli expression system
25. Prolyl endopeptidase from Aeromonas hydrophita: Cloning, sequencing, and expression of the enzyme gene, and characterization of the expressed enzyme
26. A gene from the hyperthermophile Pyrococcus furiosus whose deduced product is homologous to members of the prolyl oligopeptidase family of proteases
27. Prolyl oligopeptidase from Pyrococcus furiosus
28. Structure and localization of the mouse prolyl oligopeptidase gene
29. Lower serum prolyl endopeptidase enzyme activity in major depression: Further evidence that peptidases play a role in the pathophysiology of depression
30. Alteration in plasma prolyl oligopeptidase activity in depression, mania, and schizophrenia: Effects of antidepressants, mood stabilizers and antipsychotic drugs
31. Loss of prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5)-trisphosphate
32. Lithium therapy and signal transduction
33. Lower serum activity of prolyl oligopeptidase in anorexia and bulimia nervosa
34. Inhibition of rabbit brain prolyl endopeptidase by N-benzyloxycarbonyl-prolyl-prolinal, a transition state aldehyde inhibitor
35. Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect
36. In vitro and in vivo inhibition of prolyl endopeptidase
37. Increase of the septal vasopressin content by prolyl endopeptidase inhibitors in rats
38. New prolyl endopeptidase inhibitors: In vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane and perhydroindole derivatives
39. Prolyl oligopeptidase inhibitors: A new class of memory enhancing drugs
40. Pharmacological treatment of Alzheimer disease: From psychotropic drugs and cholinesterase inhibitors to pharmacogenomics
41. Specific inhibitor for prolyl endopeptidase suppresses the generation of amiloid β protein in NG108-15 cells
42. Prevention of amyloid-like deposition by a selective prolyl endopeptidase inhibitor, Y-29794, in senescence-accelerated mouse
43. Novel proline endopeptidase inhibitors do not modify Abeta40/42 formation and degradation by human cells expressing wild-type and swedish mutated beta-amyloid precursor protein
44. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: Angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase
45. Inactivation of prolyl endopeptidase by a peptidylchloromethane. Kinetics of inactivation and identification of sites of modification
46. The α/β hydrolase fold
47. Lipases: Three-dimensional structure and mechanism of action
48. Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases and related proteins
49. Lipases and α/β hydrolase fold
50. α/β Hydrolase fold enzymes: The family keeps growing
51. Stucture of proline iminopeptidase from Xanthomonas campestris pv. citri: A prototype for the prolyl oligopeptidase family
52. β-propellers: Structural rigidity and functional diversity
53. Cytochrom cdl. structure: Unusual haem environments in a nitrite reductase and analysis of factors contributing to β-propeller folds
54. 1.8 Å structure of the C-terminal domain of rabbit serum hemopexin
55. Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed β-propeller
56. Low-barrier hydrogen bond is absent in the catalytic triads in the ground state but is present in a transition state complex in prolyl oligopeptidase family of serine proteases
57. Structure and function of serine proteases
58. Convergence of active center geometries
59. Structures of prolyl oligopeptidase substrate/inhibitor complexes. Use of inhibitor binding for titration of the catalytic histidine residue
60. Kinetic and mechanistic studies of prolyl oligopeptidase from the hyperthermophile Pyrococcus furiosus
61. pH-Dependent mechanism in the catalysis of prolyl endopeptidase from pig muscle
62. The non-catalytic β-propeller domain ofprolyl oligopeptidase enhances the catalytic capability of the peptidase domain
63. Effects of ionic strength on the catalysis and stability of prolyl oligopeptidase
64. Prolyl oligopeptidase catalysis: Reactions with thiono substrates reveal substrate-induced conformational change to be the rate-limiting step
65. Prolyl endopeptidase catalysis. A physical rather than a chemical step is rate-limiting
66. Structural basis of substrate specificity in the serine proteases
67. Protease II from Escherichia coli
68. Chagas disease
69. Substrate specificity and inhibitor sensitivity of a trypanosomatid alkaline peptidase
70. Characterization of an endopeptidase of Trypanosorna brucei brucei
71. A potential processing enzyme in prokaryotes: Oligopeptidase B, a new type of serine peptidase
72. A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin
73. Characterisation of the antitrypanosomal activity of peptidyl alpha-aminoalkyl phosphonate diphenyl esters
74. 2+ -signalling factor for mammalian cells
75. 2+ signaling in mammalian cells
76. Oligopeptidase B-dependent signaling mediates host cell invasion by Trypanosoma cruzi
77. Dual role of signaling pathways leading to Ca(2+) and cyclic AMP elevation in host cell invasion by Trypanosoma cruzi
78. Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity
79. Oligopeptidase B: Protease II from Escherichia coli
80. Purificatioön of protease II from Escherichia coli by affinity chromatography and separation of two enzyme species from cells harvested at late log phase
81. Purification and characterization of a new 120 kDa alkaline proteinase of Trypanosoma cruzi
82. Proteases from Trypanosorna brucei brucei. Purification, characterization and interaction with host regulatory molecules
83. Oligopeptidase B
84. Oligopeptidase B: Cloning and probing stability under nonequilibrium conditions
85. Oligopeptidase B from Trypanosoma brucei, a new member of an emerging subgroup of serine oligopeptidases
86. Protease II from Moraxella lacunata: Cloning, sequencing and expression of the enzyme gene, and crystallization of the expressed enzyme
87. Construction of 3D model of oligopeptidase B, a potential processing enzyme in prokaryotes
88. Oligopeptidase B: A new type of serine peptidase with a unique substrate-dependent temperature-sensitivity
89. Dipeptidyl-peptidase IV from rat liver
90. A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide
91. Dipeptidyl-peptidase IV, a kidney brush-border serine peptidase
92. Post-proline dipeptidyl aminopeptidase (dipeptidyl aminopeptidase IV) from lamb kidney. Purification and some enzymatic properties
93. Preparation of dipeptidyl aminopeptidase IV for polypeptide sequencing
94. An amphiphilic form of dipeptidyl peptidase IV from pig small-intestinal brush-border membrane. Purification by immunoabsorbent chromatography and some properties
95. Biogenesis of plasma membrane glycoproteins
96. Comparison of dipeptidyl peptidase IV prepared from pig liver and kidney
97. Evidence for tripeptide-proton symport in renal brush border membrane vesicles. Studies in a novel rat strain with a genetic absence of dipeptidyl peptidase IV
98. Dietary regulation of rat intestinal angiotensin-converting enzyme and dipeptidyl peptidase IV
99. Lung endothelial dipeptidyl-peptidase IV is an adhesion molecule for lung-metastatic rat breast and prostate carcinoma cells
100. The cysteine-rich region of dipeptidyl-peptidase IV (CD26) is the collagen-binding site
101. Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes
102. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells
103. CD26/dipeptidyl peptidase IV in lymphocyte growth regulation
104. Dipeptidyl peptidase IV: A cell surface peptidase involved in regulating T cell growth
105. Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function
106. Enzymatic activity of DPIV/CD26 is involved in PMA-induced hyperphosphorylation of p561ck
107. Signal transduction events induced or affected by inhibition of the catalytic activity of dipeptidyl peptidase IV (DP IV, CD26)
108. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity
109. Costimulation of CD4+ and CD8+ T cells through CD26: The ADA-binding epitope is not essential for complete signaling
110. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response
111. Relating structure to function in the beta-propeller domain dipeptidyl peptidase IV. Point mutations that influence adenosine deaminase binding, antibody binding and enzyme activity
112. Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5)
113. Minireview: The glucagon-like peptides
114. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients
115. Molecular cloning and sequence analysis of human dipeptidyl-peptidase IV, a serine proteinase on the cell surface
116. Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation
117. cDNA cloning for mouse thymocyte-activating molecule. A multifunctional ecto-dipeptidyl peptidase IV (CD26) included in a subgroup of serine proteases
118. Primary structure of rat liver dipeptidyl-peptidase IV deduced from its cDNA and identification of the NH2-terminal signal sequence as the membrane-anchoring domain
119. Cloning, sequencing and expression of the dipeptidyl peptidase IV gene from Flavobacterium meningosepticum in Escherichia coli
120. Sequence analysis of the Porphyromonas gingivalis dipeptidyl peptidase IV gene
121. Dipeptidyl aminopeptidase IV from Pseudomonas sp. WO24
122. Identification of serine 624, aspartic acid 702 and histidine 734 as the catalytic triad residues of mouse dipeptidyl-peptidase IV (CD26). A member of a novel family of nonclassical serine hydrolases
123. Genomic organization, exact localization and tissue expression of human CD26 (dipeptidyl peptidase IV) gene
124. Human dipeptidyl peptidase IV gene promoter: Tissue specific regulation from TATA-less GC-rich sequence characteristic of housekeeping gene promoter
125. Expresson of dipeptidyl peptidase IV in rat tissues is mainly regulated at the mRNA levels
126. Mechanism of proline-specific proteinases: (I) Substrate specificity of dipeptidyl peptidase IV from pig kidney and proline-specific endopeptidase from Flavobacterium meningosepticum
127. Extended investigation of the substrate specificity of dipeptidyl peptidase IV from pig kidney
128. The conformation around the peptide bond between the P1- and P2-positions is important for catalytic activity of some proline-specific proteases
129. The involvement of dipeptidyl peptidase IV in brush-border degradation of GRF(1-29)NH2 by intestinal mucosal cells
130. Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences
131. Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs
132. Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria
133. Detection of dipeptidyl peptidase IV in glioma C6 and neuroblastoma SK-N-SH cell lines
134. Aminoacylpyrrolidine-2-nitriles: Potent and stable inhibitors of dipeptidyl-peptidase IV (CD 26)
135. Dipeptide-derived diphenyl phosphonate esters: Mechanism-based inhibitors of dipeptidyl peptidase IV
136. Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors
137. Separation of LPro-DL-boroPro into its component diastereomers and kinetic analysis of their inhibition of dipeptidyl peptidase IV. A new method for the analysis of slow, tight-binding inhibition
138. Acylaminoacyl peptidase
139. Enzymic cleavage of the blocked amino terminal residues of peptides
140. Genetic relationship between acylpeptide hydrolase and acylase, two hydrolytic enzymes with similar binding but different catalytic specificities
141. Removal of N-acetyl groups from blocked peptides with acylpeptide hydrolase. Stabilization of the enzyme and its application to protein sequencing
142. Purification and partial characterization of α-N-acylpeptide hydrolase from bovine liver
143. Purification and characterization of α-N-acylpeptide hydrolase from rabbit muscle
144. Bovine lens acylpeptide hydrolase. Purification and characterization of a tetrameric enzyme resistant to urea denaturation and proteolytic inactivation
145. Cloning, sequencing and further characterization of acylpeptide hydrolase from porcine intestinal mucosa
146. Deficiency of acylpeptide hydrolase in small-cell lung carcinoma cell lines
147. The primary structure of porcine liver acylamino acid-releasing enzyme deduced from cDNA sequences
148. Cloning and sequence analysis of a rat liver cDNA encoding acyl-peptide hydrolase
149. Acylpeptide hydrolase: Inhibitors and some active site residues of the human enzyme
150. Identification of the catalytic triad residues of porcine liver acylamino acid-releasing enzyme
151. Crystallization and preliminary X-ray studies of human erythrocyte acylpeptide hydrolase
152. Acylamino acid-releasing enzyme from the thermophylic archaeon Pyrococcus horikoshii
153. The DNF15S2 locus at 3p21 is transcribed in normal lung small cell lung cancer
154. The gene from the short arm of chromosome 3, at D3F15S2, frequently deleted in renal cell carcinoma, encodes acylpeptide hydrolase
155. Deficiency of acylpeptide hydrolase in small-cell lung carcinoma cell lines